Lung biopsy is a vital tool in cancer research, providing crucial tissue samples for the diagnosis and study of lung cancer. By examining these samples, researchers can identify cancer subtypes, genetic mutations, and specific biomarkers, which are essential for developing personalized treatment plans. Various biopsy techniques, including needle biopsy, bronchoscopy, and surgical biopsy, offer distinct benefits for accessing different lung regions. These samples are invaluable for investigating tumor biology, progression, and treatment response. Innovations in minimally invasive biopsy methods have improved patient safety and the precision of sample collection. Lung biopsies are therefore instrumental in advancing targeted therapies and enhancing prognostic outcomes, significantly contributing to the progress of lung cancer research and treatment.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States